Disease | pre-eclampsia |
Symptom | C0020538|hypertension |
Sentences | 43 |
PubMedID- 23732498 | hypertension in preeclampsia is an epiphenomenon which needs to be controlled at levels that reduce maternal risk without impairing placental perfusion. |
PubMedID- 23671584 | Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. |
PubMedID- 24159378 | hypertension in preeclampsia is associated with placental ischemia-induced release of anti-angiogenic soluble fms-like tyrosine kinase (sflt-1) into the maternal circulation, which antagonizes vascular endothelial growth factor (vegf) promoting endothelial dysfunction. |
PubMedID- 23087548 | we observed hypertension in 5.38% of pregnant women, and preeclampsia was the dominant cause (91.7%). |
PubMedID- 24910806 | Acute aortic dissection may occur in pregnancy in association with severe hypertension due to preeclampsia, coarctation of aorta or connective tissue disorders such as marfan's syndrome (3). |
PubMedID- 26366935 | It is controversial that uric acid (ua) levels are related to the severity of hypertension in preeclampsia (pe). |
PubMedID- 24881356 | Conclusions: the progression of gestational hypertension into preeclampsia appreciated in one of each four patients. |
PubMedID- 25330689 | Objective: to determine whether baseline serum hepatic and renal laboratory testing during routine prenatal visits in gravidas with chronic hypertension facilitates the diagnosis of superimposed preeclampsia later in pregnancy. |
PubMedID- 20399167 | hypertension occurs in 6-8% of pregnancies, preeclampsia in 2%, found to be "severe" in 0.6%. |
PubMedID- 25448508 | Study design: this was a multicenter retrospective cohort study of all pregnancies complicated by chronic hypertension with superimposed preeclampsia or mild preeclampsia expectantly managed in the hospital from january 2008 through december 2011. |
PubMedID- 23545163 | Objective: preeclampsia (pe) is associated with hypertension and elevated endothelin (et-1), an indicator of endothelial cell activation and dysfunction. |
PubMedID- 20385595 | Placental overproduction of sflt1 may contribute to the syndrome of preeclampsia with proteinuria and hypertension since recombinant sflt1 induces proteinuria in pregnant and non-pregnant rodents (6–8). |
PubMedID- 25995814 | preeclampsia is characterized with hypertension and proteinuria during pregnancy, and can have serious consequences about maternal and fetal health. |
PubMedID- 23817797 | preeclampsia is associated with hypertension and increased infant and maternal morbidity and mortality. |
PubMedID- 20948996 | It is possible that difficulty in determining the clinical diagnosis of preeclampsia in subjects with chronic hypertension and especially these and other subjects with preexisting proteinuria may have affected the results of this study. |
PubMedID- 23404257 | Maternal benefits include improved cardiovascular function, minimal weight gain during pregnancy, decreased musculoskeletal discomfort and mood stability, reduction of gdm and gestational hypertension that may lead to preeclampsia (pe). |
PubMedID- 24958504 | Analysis of urinary markers revealed higher excretion of albumin and kidney injury molecule-1 and lower excretion of neutrophil gelatinase-associated lipocalin and epithelial growth factor in severe preeclampsia compared with chronic hypertension and healthy controls. |
PubMedID- 22838249 | During expectant management 6 patients displayed hypertension with proteinuria, representing preeclampsia, by the 2nd trimester (11-24 weeks) and the other 9 did not (nonpreeclamptic). |
PubMedID- 24130940 | 30 mmhg or higher increase in systolic blood pressure and 15 mmhg or higher increase in diastolic blood pressure over the baseline values and doubling proteinuria was defined as superimposed preeclampsia in those with hypertension and proteinuria >300 mg/day. |
PubMedID- 23657513 | Results: there were significant differences between the groups in comparing severe preeclampsia with chronic hypertension and severe preeclampsia with controls (p < 0.0001 for both measurements). |
PubMedID- 22074109 | Chronic hypertension with superimposed preeclampsia was defined as known chronic hypertension associated with further worsening of blood pressure and protein excretion ≥ 3 g/day after 20 weeks gestation. |
PubMedID- 21858206 | Our current knowledge is that hypertension in preeclampsia is secondary to placental underperfusion. |
PubMedID- 23850528 | The joint association of perceived stress during pregnancy and chronic hypertension with preeclampsia was very similar to that of the joint association of lifetime stress and chronic hypertension with preeclampsia. |
PubMedID- 23793484 | Icd-9 hospital discharge diagnosis codes were used to assign hypertensive disorders hierarchically as chronic hypertension, chronic hypertension with superimposed preeclampsia, preeclampsia (eclampsia/severe or mild), or gestational hypertension. |
PubMedID- 24910751 | Gestational hypertension, diabetes), history of abortion, preeclampsia, multigravity and multiple pregnancies. |
PubMedID- 24551572 | preeclampsia is manifested with hypertension, proteinuria, and edema. |
PubMedID- 23485144 | hypertension in preeclampsia appears to be triggered by a placental factor, which leads to endothelial activation/dysfunction. |
PubMedID- 25614387 | Moreover, the risk of developing hypertension in women with preeclampsia was higher 2 years postpartum than in women without preeclampsia. |
PubMedID- 22380763 | Results: there were statistically significant differences between the groups when comparing severe preeclampsia with chronic hypertension, and severe preeclampsia with the control group (p < 0.0001). |
PubMedID- 26000015 | Captopril can be used safely and effectively in managing postpartum hypertension in women with severe preeclampsia . |
PubMedID- 22105295 | 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. |
PubMedID- 26391409 | preeclampsia in combination with preexisting hypertension conferred a significant nearly 6-fold risk in comparison with a 4-fold risk for preexisting hypertension alone. |
PubMedID- 21966796 | The most common mother complication was type renovascular hypertension with added severe preeclampsia, which determined the presence of intrauterine growth restriction. |
PubMedID- 21146124 | In this article, we review current understanding of the mechanisms of vegf-targeted therapy-induced hypertension, discuss similarities with preeclampsia, review implications for therapy of this increasingly common clinical problem, and discuss the potential use of blood pressure increase as a biomarker for proper drug dosing and effective vegf pathway inhibition. |
PubMedID- 23118594 | There is a higher risk of maternal morbidity, including arterial hypertension leading to preeclampsia or eclampsia, suicide attempts and post partum depression. |
PubMedID- 25016896 | 13 patients had s/d ratio greater than 2.6, of which 5 had gestational hypertension, 3 with preeclampsia, 1 with fetal growth restriction, 4 with normal pregnancy. |
PubMedID- 21531374 | The genetic deletion of catechol o-methyltransferase (comt) in mice produces a preeclampsia-like phenotype, with mice exhibiting hypertension, proteinuria, and histological changes, consistent with human pathological features. |
PubMedID- 24733364 | In the nchs multiple birth database, it is impossible to distinguish between gestational hypertension (without proteinuria) and preeclampsia (gestational hypertension with proteinuria). |
PubMedID- 24854625 | The risk for preeclampsia increased 12-fold with gestational hypertension (p=0.003) and 14-fold with combined chronic and gestational hypertension (p=0.001). |
PubMedID- 20513456 | The non-treated pathology is associated with higher risk of maternal morbidity, including arterial hypertension, which could lead to preeclampsia or eclampsia, ideation and suicide attempts, and postpartum depression. |
PubMedID- 21480159 | The association of hypertension with preeclampsia was expected. |
PubMedID- 20174514 | Various complications implicated in these studies were bleeding during pregnancy, abruption, hypertension and the use of diuretics, preeclampsia, and polyhydraminos. |
PubMedID- 25729662 | Short-acting sublingual nifedipine, a calcium channel blocker, is another effective antihypertensive agent that is sometimes used to control acute, severe hypertension in women with preeclampsia (16, 17). |
Page: 1